BDBM284360 4-(6-(4-(5-cyclopropyl- 1H-pyrazole-3- carbonyl)piperazin-1- yl)pyridin-3-yl)-6-(1- methyl-1H-pyrazol-4- yl)pyrazolo[1,5- a]pyridine-3-carbonitrile bis(2,2,2-trifluoroacetate)::US10023570, Example 370::US10174027, Example 370

SMILES Cn1cc(-c2cc(-c3ccc(N4CCN(C(=O)c5cc(C6CC6)[nH]n5)CC4)nc3)c3c(C#N)cnn3c2)cn1

InChI Key InChIKey=RMQMDPRTBLQACF-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 284360   

LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 2.5nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/10/2019
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 2.5nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 2.5nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 9.40nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/10/2019
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 9.40nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 284360BDBM284360(US10023570, Example 370 | 4-(6-(4-(5-cyclopropyl- ...)
Affinity DataIC50: 9.40nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent